Skip to content

Quinine

Antimalarial — MUSCULO-SKELETAL SYSTEM

Also known as: chinine, qualaquin, quinine bisulfate heptahydrate, quinine sulfate

OfpFDA approvedATC M09AA72ATC P01BC01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Quinine is an ofp drug in the Antimalarial class catalogued in DrugCentral. It was first approved by the FDA in 2005. DrugCentral lists 7 molecular targets, including SCN1A|SCN2A|SCN3A, ABCB1 and KCNB2. Recorded indications include Chloroquine Resistant Plasmodium Falciparum Malaria and Falciparum malaria.

  • Approval status: ofp (first approved 2005 by the FDA).
  • Drug class: Antimalarial.
  • Molecular targets: SCN1A|SCN2A|SCN3A, ABCB1, KCNB2 and SLC29A4 (7 listed in DrugCentral).
  • Indications: Chloroquine Resistant Plasmodium Falciparum Malaria and Falciparum malaria.
  • ATC code: M09AA72 (Quinine and derivatives).
  • Molecular formula: C20H24N2O2; molecular weight 324.42 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Chloroquine Resistant Plasmodium Falciparum Malaria
  • Falciparum malaria

Off-label uses (1)

  • Babesiosis

Contraindications (17)

  • Acute nephropathy
  • Anemia due to enzyme deficiency
  • Atrial fibrillation
  • Atrial flutter
  • Black water fever
  • Congenital long QT syndrome
  • Disease of liver
  • End stage renal disease
  • Hemolytic uremic syndrome
  • Hypoglycemic disorder
  • Myasthenia gravis
  • Neuromuscular block, function
  • Optic neuritis
  • Prolonged QT interval
  • Thrombocytopenic disorder
  • Thrombotic thrombocytopenic purpura
  • Torsades de pointes

Mechanism & targets

Established pharmacologic classAntimalarial

Molecular targets (7)

TargetGeneActionActivity
Sodium channel alpha subunits; brain (Types I, II, III)SCN1A|SCN2A|SCN3AunknownIC50 5.36
Multidrug resistance protein 1ABCB1unknownKi 4.92
Potassium voltage-gated channel subfamily B member 2KCNB2blockerIC50 4.90
Equilibrative nucleoside transporter 4SLC29A4inhibitorKi 4.57
Solute carrier family 22 member 1SLC22A1unknownIC50 4.29
Hemoglobin subunit alphaHBA1unknown—
Potassium voltage-gated channel subfamily H member 2KCNH2unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2005-08-12FDA—MUTUAL PHARM CO INC

ATC classification

ATC codeTherapeutic hierarchy
M09AA72MUSCULO-SKELETAL SYSTEM › OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM › OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM › Quinine and derivatives
P01BC01ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Methanolquinolines

Pharmacogenomics

Drug-label and guideline annotations from PharmGKB and CPIC.

  • FDA label: G6PD · Actionable PGx
  • FDA label: CYP2D6
  • HCSC label: G6PD · Actionable PGx
  • Swissmedic label: G6PD · Actionable PGx

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Drug abuse1541.1
Toxicity to various agents438.8
Sedation complication184.1
Thrombotic microangiopathy178.0
Labile blood pressure153.7
Cinchonism126.8
Blood calcium decreased122.0
Creatinine renal clearance decreased121.7
Renal function test abnormal120.1
Creatinine renal clearance increased119.0
Somatic symptom disorder115.6
Cognitive disorder109.4

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Quinine is on its molecule page.

Molecular formulaC20H24N2O2
Molecular weight324.42 g/mol
CAS number—
InChIKeyLOUPRKONTZGTKE-WZBLMQSHSA-N
PubChem CID3034034
COC1=CC=C2N=CC=C([C@@H](O)[C@@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)C2=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Quinine used for?

DrugCentral lists the following indications for Quinine: Chloroquine Resistant Plasmodium Falciparum Malaria and Falciparum malaria.

How does Quinine work?

Its molecular targets in DrugCentral include SCN1A|SCN2A|SCN3A, ABCB1, KCNB2 (blocker) and SLC29A4 (inhibitor).

When was Quinine first approved?

Quinine was first approved by the FDA in 2005.

What drug class does Quinine belong to?

Quinine is in the Antimalarial class.

What is the chemical formula of Quinine?

Quinine has the molecular formula C20H24N2O2 and a molecular weight of 324.42 g/mol.

Browse: all drugs starting with Q · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval2005-08-12
AgencyFDA
Targets7
Indications2
FormulaC20H24N2O2
DrugCentral ID4523
Interactive profile